Seoul, South Korea – A growing focus on improving access to treatment for chronic and debilitating skin conditions, particularly chronic hand eczema, is gaining momentum in South Korea. On March 19, 2026, a policy seminar co-hosted by Member of Parliament Lee Ju-young of the Reform Party and the Korean Society of Contact Dermatitis and Skin Allergy (KSCDA) will address the challenges faced by patients and explore potential policy solutions. This initiative underscores a critical need to address the often-overlooked impact of severe, intractable skin diseases on patients’ quality of life and economic productivity.
Chronic hand eczema, a persistent and often debilitating inflammatory skin condition, affects a significant portion of the population, impacting daily activities and professional lives. While topical corticosteroids are currently the first-line treatment, long-term use can lead to adverse effects and diminished efficacy, leaving many patients with limited options. The seminar aims to shed light on the unmet medical needs of these individuals and to foster a dialogue on innovative approaches to care. According to the Korean News Communication, the event will bring together medical professionals, patient advocates, policymakers, and representatives from the insurance industry to collaboratively seek solutions.
Addressing the Challenges of Chronic Hand Eczema
The policy seminar, titled “Current Status of Severe Intractable Skin Diseases and Policy Alternatives for Improving Patient Access to Treatment: Focusing on Chronic Hand Eczema,” will be held at the 10th Conference Room of the National Assembly Hall at 2:00 PM on March 19, 2026. The event is structured to provide a comprehensive overview of the condition, from its prevalence and impact to the latest treatment modalities and the barriers to access. The KSCDA, a leading professional organization dedicated to the study and treatment of contact dermatitis and skin allergies, is playing a pivotal role in shaping the discussion and advocating for improved patient care.
Professor Go Ju-yeon of the Department of Dermatology at Hanyang University Hospital, and current president of the KSCDA, will chair the seminar. Professor Kim Hye-won of the Department of Dermatology at Hanlim University Gangnam Sacred Heart Hospital, serving as the KSCDA’s general affairs director, will deliver a keynote presentation on the current status and latest treatment trends for chronic hand eczema in South Korea. A short video aimed at raising awareness of the condition will also be screened, highlighting the lived experiences of patients and the challenges they face. The KSCDA was founded in 1988 and has been instrumental in advancing dermatological research and clinical practice in the country.
A Multi-Stakeholder Approach to Policy Development
The seminar’s panel discussion will feature a diverse group of stakeholders, including clinicians, patient representatives, journalists, insurance representatives, and government officials. Professor Jeon Ji-hyun of the Department of Dermatology at Korea University Guro Hospital, the KSCDA’s treasurer, will moderate the discussion. Participants include Park Jo-eun, president of the Severe Atopic Dermatitis Association; Kwon Sun-mi, a journalist with the Chungang Ilbo newspaper; Kim Chung-yeol, an official from the Insurance and Pharmaceutical Division of the Ministry of Health and Welfare; Kim Hyung-min, a department head at the National Health Insurance Service; and Lee Suk-hyun, a department head at the Health Insurance Review and Assessment Service. This broad representation underscores the need for a collaborative, multi-faceted approach to addressing the challenges of chronic hand eczema.
MP Lee Ju-young intends to use the seminar as a platform to emphasize that chronic hand eczema is not merely a superficial skin condition but a chronic, relapsing inflammatory disease that significantly impacts patients’ daily lives and ability to function. He aims to focus the discussion on the need to improve the treatment environment and ensure that patients have access to the care they need. The Reform Party, founded in 2024, has positioned itself as a proponent of pragmatic policy solutions and has shown a commitment to addressing healthcare challenges. As reported by the Dong-A Ilbo, the seminar is intended to address a “policy blind spot” regarding this condition.
The Limitations of Current Treatment Options
Currently, the primary treatment for chronic hand eczema is topical corticosteroids. However, prolonged use of these medications can lead to side effects, including skin thinning, striae, and telangiectasias. The effectiveness of topical corticosteroids can diminish over time, leading to treatment failure and a cycle of exacerbations and remissions. This highlights the need for alternative treatment options and a more comprehensive approach to managing the condition. Research into novel therapies, such as biologics and topical calcineurin inhibitors, is ongoing, but access to these treatments may be limited by cost and regulatory hurdles.
The seminar will likely explore the potential for expanding insurance coverage for newer, more effective treatments, as well as streamlining the approval process for innovative therapies. The National Health Insurance Service (NHIS) plays a crucial role in determining which treatments are covered and at what level. The Health Insurance Review and Assessment Service (HIRA) is responsible for evaluating the clinical effectiveness and cost-effectiveness of latest treatments before they are added to the NHIS formulary. Navigating these regulatory pathways can be challenging for pharmaceutical companies and can delay access to potentially life-changing therapies for patients.
Looking Ahead: Policy Implications and Patient Advocacy
The outcome of the March 19th seminar could have significant implications for healthcare policy in South Korea. By bringing together key stakeholders and raising awareness of the challenges faced by patients with chronic hand eczema, the event has the potential to catalyze meaningful change. The discussions are expected to focus on several key areas, including improving access to specialized dermatological care, expanding insurance coverage for innovative treatments, and promoting greater awareness of the condition among healthcare professionals and the general public.
Patient advocacy groups, such as the Severe Atopic Dermatitis Association, are playing an increasingly important role in shaping healthcare policy. These organizations provide a voice for patients, raise awareness of unmet needs, and advocate for policies that improve access to care. The participation of Park Jo-eun, president of the association, in the seminar’s panel discussion underscores the importance of patient perspectives in the policy-making process. The association actively works to support patients and their families, providing information, resources, and a platform for sharing experiences.
The seminar represents a crucial step towards addressing the challenges of chronic hand eczema and improving the lives of those affected by this debilitating condition. The collaborative approach, bringing together medical professionals, policymakers, and patient advocates, offers a promising path forward. The next step will be to translate the insights gained from the seminar into concrete policy recommendations and to advocate for their implementation. Further updates on the outcomes of the seminar and any resulting policy changes will be closely monitored.
Key Takeaways:
- A policy seminar on chronic hand eczema will be held on March 19, 2026, in Seoul, South Korea.
- The event is co-hosted by MP Lee Ju-young and the Korean Society of Contact Dermatitis and Skin Allergy (KSCDA).
- The seminar aims to improve patient access to treatment and address unmet medical needs.
- Stakeholders from various sectors, including healthcare, government, and patient advocacy, will participate.
We encourage readers to share their thoughts and experiences with chronic skin conditions in the comments below. Stay tuned to World Today Journal for further updates on this important issue.
Related reading